FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ondansetron Hydrochloride Injection
Status: Resolved
»Duration of Shortage: 04/11/2018 - 04/25/2022
»Therapeutic Categories: Gastroenterology

Expand all

Apotex Corp. (Revised 04/25/2022)

Company Contact Information:
800-706-5575

Presentation
  • Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05)
Note:
  • Available

Baxter Healthcare (Revised 04/25/2022)

Company Contact Information:
800-229-0001

Presentation
  • Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)
Note:
  • Available

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Revised 04/25/2022)

Company Contact Information:
888-238-7880

Presentation
  • 2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)
  • 2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)
Note:
  • N/A

Fresenius Kabi USA, LLC (Revised 04/25/2022)

Company Contact Information:
888-386-1300

Presentation
  • Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)
  • Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)
  • Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)
Note:
  • Available

Gland Pharma Limited (Revised 04/25/2022)

Company Contact Information:
609-250-7990

Presentation
  • 2 mg/mL 2mL vial (NDC 70860-776-02)
  • 2 mg/mL 20mL vial (NDC 70860-777-20)
  • 2 mg/mL, 2 mL vial (NDC 72266-123-25)
  • 2 mg/mL, 20 mL vial (NDC 72266-124-01)
Note:
  • Available

Heritage Pharma (Revised 04/25/2022)

Company Contact Information:
866-901-1230

Presentation
  • 2 mg/mL , 20 mL vials (NDC 23155-549-31)
  • PPRX 2 mg/mL , 2 mL Vial, 25 pack (NDC 23155-548-42)
  • PPRX 2 mg/mL , 2 mL Vial, 10 pack (NDC 23155-548-41)
  • 2 mg/mL , 2 mL Vial (NDC 23155-547-41)
Note:
  • N/A

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/25/2022)

Company Contact Information:
800-631-2174

Presentation
  • 2 mg/mL, 2 mL vial (NDC 0641-6078-25)
  • 2 mg/mL, 20 mL vial (NDC 0143-9890-01)
Note:
  • Available

Hospira, Inc. (Revised 04/25/2022)

Company Contact Information:
844-646-4398

Presentation
  • 4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03)
  • 40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01)
Note:
  • N/A

Sagent Pharmaceuticals (Revised 04/25/2022)

Company Contact Information:
866-625-1618

Presentation
  • 40mg/20mL EA 1 Vial (NDC 25021-782-20)
  • 4mg/2mL PK 25 Vials (NDC 25021-777-02)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English